AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

1.031%

12M weight contribution

+0.265 pp

3M weight contribution

+0.099 pp

12M price return

+24.0%

Share of matched S&P 500 members

Monthly observations through Dec 2022

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Dec 2022	$285.8bn	1.031%	+0.265 pp	+24.0%	Yes
Nov 2022	$285.0bn	0.967%	+0.279 pp	+45.3%	Yes
Oct 2022	$258.8bn	0.919%	+0.242 pp	+32.6%	No
Sep 2022	$237.3bn	0.933%	+0.263 pp	+29.5%	Yes
Aug 2022	$237.7bn	0.851%	+0.137 pp	+15.9%	No
Jul 2022	$253.6bn	0.871%	+0.167 pp	+28.5%	No
Jun 2022	$270.7bn	1.053%	+0.350 pp	+41.8%	Yes
May 2022	$260.4bn	0.938%	+0.222 pp	+35.8%	Yes
Apr 2022	$259.8bn	0.939%	+0.226 pp	+37.4%	Yes
Mar 2022	$286.7bn	0.965%	+0.591 pp	+56.8%	Yes
Feb 2022	$261.4bn	0.907%	+0.526 pp	+43.5%	Yes
Jan 2022	$242.0bn	0.814%	+0.381 pp	+39.8%	Yes
Dec 2021	$239.4bn	0.767%	+0.001 pp	+32.4%	Yes
Nov 2021	$203.8bn	0.689%	-0.096 pp	+15.5%	No
Oct 2021	$202.6bn	0.677%	-0.034 pp	+41.2%	No
Sep 2021	$190.6bn	0.669%	+0.669 pp	+29.3%	No
Aug 2021	$213.4bn	0.714%	+0.713 pp	+32.4%	Yes
Jul 2021	$205.4bn	0.704%	+0.704 pp	+28.6%	Yes
Jun 2021	$198.9bn	0.702%	+0.702 pp	+20.5%	Yes
May 2021	$199.9bn	0.716%	+0.715 pp	+28.3%	Yes
Apr 2021	$196.9bn	0.714%	+0.033 pp	+42.5%	Yes
Mar 2021	$191.1bn	0.374%	+0.373 pp	+49.6%	No
Feb 2021	$190.3bn	0.380%	+0.380 pp	+32.4%	No
Jan 2021	$180.9bn	0.433%	-0.158 pp	+33.3%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.